Quadrature Capital’s RAPT Therapeutics RAPT Stock Holding History

Quadrature Capital’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-57,590	Closed	-$1.95M	–	1764
2025 Q4	$1.95M	Buy	+57,590	New	+$1.79M	0.02%	374

Quadrature Capital's RAPT Position: Q1 2026 in Review

Quadrature Capital sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 57,590 shares — an estimated $1.95M sold.

Quadrature Capital first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $1.95M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Quadrature Capital reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Quadrature Capital sold 57,590 RAPT Therapeutics shares in Q1 2026, an estimated $1.95M.
Quadrature Capital first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Quadrature Capital's RAPT Therapeutics position peaked at $1.95M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.